Johnson & Johnson - Payout Ratio History
Payout ratio history for stock JNJ (Johnson & Johnson).
| Date | Payout ratio |
|---|---|
| February 2023 | 41.43% |
| January 2023 | 43.42% |
| December 2022 | 43.46% |
| November 2022 | 43.38% |
| October 2022 | 42.68% |
| September 2022 | 43.46% |
| August 2022 | 43.55% |
| July 2022 | 43.38% |
| June 2022 | 43.38% |
| May 2022 | 40.69% |
| April 2022 | 40.69% |
| March 2022 | 40.69% |
| February 2022 | 40.69% |
| January 2022 | 40.69% |
| December 2021 | 40.69% |
| October 2021 | 63.76% |
| September 2021 | 63.76% |
| August 2021 | 74.91% |
| July 2021 | 74.91% |
| June 2021 | 74.91% |
| May 2021 | 73.32% |
| April 2021 | 73.32% |
| March 2021 | 73.32% |
| February 2021 | 63.52% |
| January 2021 | 63.52% |
| December 2020 | 59.75% |
| November 2020 | 58.90% |
| October 2020 | 65.90% |
| September 2020 | 65.90% |
| August 2020 | 65.90% |
| July 2020 | 58.43% |
| June 2020 | 58.43% |
| May 2020 | 67.74% |
| April 2020 | 67.74% |
| March 2020 | 67.74% |
| February 2020 | 67.74% |
| January 2020 | 67.74% |
| December 2019 | 67.74% |
| November 2019 | 67.74% |
| October 2019 | 67.74% |
| September 2019 | 67.74% |
| August 2019 | 67.74% |
| July 2019 | 67.74% |
| June 2019 | 67.74% |
| May 2019 | 67.74% |
| April 2019 | 64.17% |
| March 2019 | 64.17% |
| February 2019 | 64.17% |
| December 2018 | 589.80% |
| December 2017 | 57% |
| December 2016 | 54.40% |
| December 2015 | 55.60% |
| December 2014 | 45% |
| December 2013 | 56.70% |
| December 2012 | 62.10% |
| December 2011 | 54.10% |
| December 2010 | 44.10% |
| December 2009 | 43.80% |
| December 2008 | 43.05% |
| December 2007 | 43.24% |
| December 2006 | 43.14% |
| December 2005 | 42.31% |
| December 2004 | 42.18% |
| December 2003 | 43.93% |
| December 2002 | 41.84% |
| December 2001 | 41.34% |
| December 2000 | 41.73% |
| December 1999 | 42.27% |
JNJ
List: Champions
Price: 162.18USD
Dividend Yield: 2.63%
Forward Dividend Yield: 2.77%
Payout Ratio: 41.43%
Dividend Per Share: 4.52 USD
Earnings Per Share: 10.91 USD
P/E Ratio: 25.10
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers—General
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 441.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 62
DGR3: 5.61%
DGR5: 5.79%
DGR10: 6.40%
DGR20: 9.35%